Transcriptional responses in thyroid tissues from rats treated with a tumorigenic and a non-tumorigenic triazole conazole fungicide.

Conazoles are azole-containing fungicides that are used in agriculture and medicine. Conazoles can induce follicular cell adenomas of the thyroid in rats after chronic bioassay. The goal of this study was to identify pathways and networks of genes that were associated with thyroid tumorigenesis through transcriptional analyses. To this end, we compared transcriptional profiles from tissues of rats treated with a tumorigenic and a non-tumorigenic conazole. Triadimefon, a rat thyroid tumorigen, and myclobutanil, which was not tumorigenic in rats after a 2-year bioassay, were administered in the feed to male Wistar/Han rats for 30 or 90 days similar to the treatment conditions previously used in their chronic bioassays. Thyroid gene expression was determined using high density Affymetrix GeneChips (Rat 230_2). Gene expression was analyzed by the Gene Set Expression Analyses method which clearly separated the tumorigenic treatments (tumorigenic response group (TRG)) from the non-tumorigenic treatments (non-tumorigenic response group (NRG)). Core genes from these gene sets were mapped to canonical, metabolic, and GeneGo processes and these processes compared across group and treatment time. Extensive analyses were performed on the 30-day gene sets as they represented the major perturbations. Gene sets in the 30-day TRG group had over representation of fatty acid metabolism, oxidation, and degradation processes (including PPARgamma and CYP involvement), and of cell proliferation responses. Core genes from these gene sets were combined into networks and found to possess signaling interactions. In addition, the core genes in each gene set were compared with genes known to be associated with human thyroid cancer. Among the genes that appeared in both rat and human data sets were: Acaca, Asns, Cebpg, Crem, Ddit3, Gja1, Grn, Jun, Junb, and Vegf. These genes were major contributors in the previously developed network from triadimefon-treated rat thyroids. It is postulated that triadimefon induces oxidative response genes and activates the nuclear receptor, Ppargamma, initiating transcription of gene products and signaling to a series of genes involved in cell proliferation.

[1]  D. Barrett,et al.  Peroxisome proliferator activated receptor alpha regulates a male-specific cytochrome P450 in mouse liver. , 2004, Archives of biochemistry and biophysics.

[2]  S. Nesnow,et al.  Gene expression profiling in the liver of CD-1 mice to characterize the hepatotoxicity of triazole fungicides. , 2006, Toxicology and applied pharmacology.

[3]  Yumiko Sakai,et al.  Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro. , 2004, Mutation research.

[4]  N. Eberhardt,et al.  The Paired Box-8/Peroxisome Proliferator-Activated Receptor-γ Oncogene in Thyroid Tumorigenesis , 2007 .

[5]  R. E. Duggan,et al.  Pesticide Residues in Food , 1973 .

[6]  A. Kong,et al.  Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.

[7]  Xidong Jin,et al.  Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. , 2004, Mutation research.

[8]  P. Parini,et al.  Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice Published, JLR Papers in Press, November 1, 2005. , 2006, Journal of Lipid Research.

[9]  R. Hammer,et al.  Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα , 1998, Cell.

[10]  David J Dix,et al.  Effect of conazole fungicides on reproductive development in the female rat. , 2006, Reproductive toxicology.

[11]  Philippe Vielh,et al.  Gene Expression Profiling of Differentiated Thyroid Neoplasms , 2004, Clinical Cancer Research.

[12]  T. Kroll.  Molecular events in follicular thyroid tumors. , 2004, Cancer treatment and research.

[13]  Z. Hall.  Cancer , 1906, The Hospital.

[14]  M. Willingham,et al.  PPARγ insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-κB signaling pathway , 2006, Oncogene.

[15]  David E. Misek,et al.  Delineation, Functional Validation, and Bioinformatic Evaluation of Gene Expression in Thyroid Follicular Carcinomas with the PAX8-PPARG Translocation , 2006, Clinical Cancer Research.

[16]  H. van den Bossche,et al.  In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis , 1980, Antimicrobial Agents and Chemotherapy.

[17]  David J Dix,et al.  Disruption of testosterone homeostasis as a mode of action for the reproductive toxicity of triazole fungicides in the male rat. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  K. Nephew,et al.  Multiple Signaling Pathways Converge on β-Catenin in Thyroid Cancer , 2005 .

[19]  S. Nesnow,et al.  Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice. , 2006, Toxicology letters.

[20]  Frank Beier,et al.  Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development , 2007, BMC Genomics.

[21]  C. Barden,et al.  Classification of follicular thyroid tumors by molecular signature: results of gene profiling. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  M. Ingelman-Sundberg,et al.  Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). , 1994, Biochemical pharmacology.

[23]  T. Crisp,et al.  Risk assessment of thyroid follicular cell tumors. , 1998, Environmental health perspectives.

[24]  D J Dix,et al.  Induction of cytochrome P450 enzymes in rat liver by two conazoles, myclobutanil and triadimefon , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[25]  F. de Longueville,et al.  Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray. , 2002, Biochemical pharmacology.

[26]  M. De Brabander,et al.  The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. , 1980, Sabouraudia.

[27]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Dix,et al.  Gene expression profiling in liver and testis of rats to characterize the toxicity of triazole fungicides. , 2006, Toxicology and applied pharmacology.

[29]  K. Nephew,et al.  Multiple signaling pathways converge on beta-catenin in thyroid cancer. , 2005, Thyroid : official journal of the American Thyroid Association.

[30]  T J Walsh,et al.  Antifungal agents: chemotherapeutic targets and immunologic strategies , 1996, Antimicrobial agents and chemotherapy.

[31]  U. Kintscher,et al.  Regulation of Peroxisome Proliferator–Activated Receptor &ggr; Activity by Losartan Metabolites , 2006, Hypertension.

[32]  G. F. Reidy,et al.  The effects of propiconazole on hepatic xenobiotic biotransformation in the rat. , 1988, Biochemical pharmacology.

[33]  H. Pershadsingh.  Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-gamma. , 2006, The international journal of biochemistry & cell biology.

[34]  T. Imai,et al.  Sequential Analysis of Development of Invasive Thyroid Follicular Cell Carcinomas in Inflamed Capsular Regions of Rats Treated with Sulfadimethoxine after N-bis(2-hydroxypropyl)nitrosamine-initiation , 2004, Toxicologic pathology.

[35]  A. Baranova,et al.  PPARγ activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFβ signalling , 2007, Journal of cellular and molecular medicine.

[36]  R G Ulrich,et al.  Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. , 2001, Toxicology and applied pharmacology.

[37]  Russell S. Thomas,et al.  Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  F. de Longueville,et al.  An evaluation of a low-density DNA microarray using cytochrome P450 inducers. , 2003, Chemical research in toxicology.

[39]  M. Willingham,et al.  PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway. , 2006, Oncogene.

[40]  T. Dwight,et al.  Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPARγ fusion oncogene , 2005, Oncogene.

[41]  S. Toyokuni,et al.  Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. , 2004, Cancer letters.

[42]  Tanya Moore,et al.  Toxicity Profiles in Mice Treated with Hepatotumorigenic and Non-Hepatotumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil , 2006, Toxicologic pathology.

[43]  W. Welsh,et al.  Molecular Characterization of Thyroid Toxicity: Anchoring Gene Expression Profiles to Biochemical and Pathologic End Points , 2005, Environmental health perspectives.

[44]  Zheng Li,et al.  Private provider participation in statewide immunization registries , 2006, BMC public health.

[45]  R. Wolfinger,et al.  A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  U. Kintscher,et al.  Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity. , 2005, Diabetes.

[47]  Mark D. Johnson,et al.  A gene expression signature for oxidant stress/reactive metabolites in rat liver. , 2004, Biochemical pharmacology.

[48]  J. Schlatter,et al.  Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase. , 2002, Environmental health perspectives.

[49]  Susan D. Hester,et al.  Transcriptional Profiles in Liver from Mice Treated with Hepatotumorigenic and Nonhepatotumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil , 2006, Toxicologic pathology.

[50]  Shen-Liang Chen,et al.  Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. , 2004, Endocrinology.

[51]  S. Nesnow,et al.  Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver. , 2005, Toxicology letters.

[52]  S. Kliewer,et al.  Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. , 2002, Molecular pharmacology.

[53]  Tanya Moore,et al.  Toxicity Profiles in Rats Treated with Tumorigenic and Nontumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil , 2006, Toxicologic pathology.